相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。NF1 mutations in conjunctival melanoma
S. L. Scholz et al.
BRITISH JOURNAL OF CANCER (2018)
Emerging genotype-phenotype relationships in patients with large NF1 deletions
Hildegard Kehrer-Sawatzki et al.
HUMAN GENETICS (2017)
Master Regulators of Oncogenic KRAS Response in Pancreatic Cancer: An Integrative Network Biology Analysis
Shivan Sivakumar et al.
PLOS MEDICINE (2017)
Whole Exome Sequencing of Growing and Non-Growing Cutaneous Neurofibromas from a Single Patient with Neurofibromatosis Type 1
Daniel L. Faden et al.
PLOS ONE (2017)
Methylation-based classification of benign and malignant peripheral nerve sheath tumors
Manuel Roehrich et al.
ACTA NEUROPATHOLOGICA (2016)
The use of electrodessication in the treatment of cutaneous neurofibromatosis: A retrospective patient satisfaction outcome assessment
C. G. Lutterodt et al.
JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY (2016)
Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas
Eva Dombi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
Bo Li et al.
GENOME BIOLOGY (2016)
Ketotifen Suppression of NF1 Neurofibroma Growth Over 30 Years
Vincent M. Riccardi
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2015)
Arg1809 substitution in neurofibromin: further evidence of a genotype-phenotype correlation in neurofibromatosis type 1
Claudia Santoro et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2015)
High-resolution 400K oligonucleotide array comparative genomic hybridization analysis of neurofibromatosis type 1-associated cutaneous neurofibromas
Akiko Asai et al.
GENE (2015)
Endocrine Implications of Neurofibromatosis 1 in Childhood
Carla Bizzarri et al.
HORMONE RESEARCH IN PAEDIATRICS (2015)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
Use of imatinib in a patient with cutaneous vasculopathy in the context of von Recklinghausen disease/neurofibromatosis
I. Khelifa et al.
BRITISH JOURNAL OF DERMATOLOGY (2015)
Somatic neurofibromatosis type 1 (NF1) inactivation events in cutaneous neurofibromas of a single NF1 patient
Denise Emmerich et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2015)
Sirolimus for progressive neurofibromatosis type 1-associated plexiform neurofibromas: a Neurofibromatosis Clinical Trials Consortium phase II study
Brian Weiss et al.
NEURO-ONCOLOGY (2015)
A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor
Nancy Ratner et al.
NATURE REVIEWS CANCER (2015)
A clinical and genetic overview of 18 years neurofibromatosis type 1 molecular diagnostics in the Netherlands
R. van Minkelen et al.
CLINICAL GENETICS (2014)
Neurofibromatosis Type 1 Alternative Splicing Is a Key Regulator of Ras Signaling in Neurons
Melissa N. Hinman et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
Comparative study of CO2- and Er:YAG laser ablation of multiple cutaneous neurofibromas in von Recklinghausen's disease
Lukas K. Kriechbaumer et al.
LASERS IN MEDICAL SCIENCE (2014)
PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies
Thomas De Raedt et al.
NATURE (2014)
Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer
Kai Wang et al.
NATURE GENETICS (2014)
PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors
William Lee et al.
NATURE GENETICS (2014)
Neurofibroma-associated macrophages play roles in tumor growth and response to pharmacological inhibition
Carlos E. Prada et al.
ACTA NEUROPATHOLOGICA (2013)
Neurofibromatosis type 1 and pregnancy: Maternal complications and attitudes about prenatal diagnosis
Claudia Cesaretti et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2013)
MicroRNAome profiling in benign and malignant neurofibromatosis type 1-associated nerve sheath tumors: evidences of PTEN pathway alterations in early NF1 tumorigenesis
Julien Masliah-Planchon et al.
BMC GENOMICS (2013)
NF1 gene silencing induces upregulation of vascular endothelial growth factor expression in both Schwann and non-Schwann cells
Yasuhiro Kawachi et al.
EXPERIMENTAL DERMATOLOGY (2013)
MicroRNA-193b Enhances Tumor Progression via Down Regulation of Neurofibromin 1
Michelle Lenarduzzi et al.
PLOS ONE (2013)
Radiofrequency Ablation and Excision of Multiple Cutaneous Lesions in Neurofibromatosis Type 1
Seong-Hun Kim et al.
ARCHIVES OF PLASTIC SURGERY-APS (2013)
Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problems
Fausto J. Rodriguez et al.
ACTA NEUROPATHOLOGICA (2012)
Psychological Burden in Adult Neurofibromatosis Type 1 Patients: Impact of Disease Visibility on Body Image
Sofia Granstroem et al.
DERMATOLOGY (2012)
Exploring the somatic NF1 mutational spectrum associated with NF1 cutaneous neurofibromas
Laura Thomas et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2012)
Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial
Kent A. Robertson et al.
LANCET ONCOLOGY (2012)
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
Martin Peifer et al.
NATURE GENETICS (2012)
Quantitative Assessment of Whole-Body Tumor Burden in Adult Patients with Neurofibromatosis
Scott R. Plotkin et al.
PLOS ONE (2012)
Carbon Dioxide Laser Treatment of Cutaneous Neurofibromas
Yi Zhen Chiang et al.
DERMATOLOGY AND THERAPY (2012)
The Development of Cutaneous Neurofibromas
Eeva-Mari Jouhilahti et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Malignant peripheral nerve sheath tumours in NF1: Improved survival in women and in recent years
Sarah Ingham et al.
EUROPEAN JOURNAL OF CANCER (2011)
Analysis of steroid hormone effects on xenografted human NF1 tumor Schwann cells
Hua Li et al.
CANCER BIOLOGY & THERAPY (2010)
NF1 Microdeletions in Neurofibromatosis Type 1: From Genotype to Phenotype
Eric Pasmant et al.
HUMAN MUTATION (2010)
Genomic Changes in Chromosomes 10, 16, and X in Malignant Peripheral Nerve Sheath Tumors Identify a High-Risk Patient Group
Helge R. Brekke et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Clinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions
V-F Mautner et al.
JOURNAL OF MEDICAL GENETICS (2010)
Analysis of NF1 somatic mutations in cutaneous neurofibromas from patients with high tumor burden
Laura Thomas et al.
NEUROGENETICS (2010)
Unravelling the genetic basis of variable clinical expression in neurofibromatosis 1
Audrey Sabbagh et al.
HUMAN MOLECULAR GENETICS (2009)
Clinical and Mutational Spectrum of Neurofibromatosis Type 1-like Syndrome
Ludwine Messiaen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Neurofibromatosis type 1
Kevin P. Boyd et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)
Absence of cutaneous neurofibromas in an NF1 patient with an atypical deletion partially overlapping the common 1.4 Mb microdeleted region
Hildegard Kehrer-Sawatzki et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2008)
Plexiform and dermal neurofibromas and pigmentation are caused by Nf1 loss in desert hedgehog-expressing cells
Jianqiang Wu et al.
CANCER CELL (2008)
Nf1-Dependent Tumors Require a Microenvironment Containing Nf1+/- and c-kit-Dependent Bone Marrow
Feng-Chun Yang et al.
CELL (2008)
Differential expression of angiogenic factors in peripheral nerve sheath tumors
Junji Wasa et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
High-resolution DNA copy number profiling of malignant peripheral nerve sheath tumors using targeted microarray-based comparative genomic hybridization
Kiran K. Mantripragada et al.
CLINICAL CANCER RESEARCH (2008)
Germline and somaticNF1gene mutations in plexiform neurofibromas
Meena Upadhyaya et al.
HUMAN MUTATION (2008)
Schwann cells from human neurofibromas show increased proliferation rates under the influence of progesterone
Anja Overdiek et al.
PEDIATRIC RESEARCH (2008)
Microneedles permit transdermal delivery of a skin-impermeant medication to humans
Daniel P. Wermeling et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Conditional N-rasG12V expression promotes manifestations of neuro. bromatosis in a mouse model
H. Saito et al.
ONCOGENE (2007)
In vitro studies of steroid hormones in neurofibromatosis 1 tumors and Schwann cells
Lauren Fishbein et al.
MOLECULAR CARCINOGENESIS (2007)
Guidelines for the diagnosis and management of individuals with neurofibromatosis 1
Rosalie E. Ferner et al.
JOURNAL OF MEDICAL GENETICS (2007)
An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in Exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation
M. Upadhyaya et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Nf1± mast cells induce neurofibroma like phenotypes through secreted TGF-β signaling
Feng-Chun Yang et al.
HUMAN MOLECULAR GENETICS (2006)
The Heterogeneous Nature of Germline Mutations in NF1 Patients With Malignant Peripheral Serve Sheath Tumours (MPNSTs)
Meena Upadhyaya et al.
HUMAN MUTATION (2006)
The NF1 tumor suppressor critically regulates TSC2 and mTOR
CM Johannessen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Identification of growth hormone receptor in localised neurofibromas of patients with neurofibromatosis type 1
KSG Cunha et al.
JOURNAL OF CLINICAL PATHOLOGY (2003)
Expression of angiogenic factors in neurofibromas
Y Kawachi et al.
EXPERIMENTAL DERMATOLOGY (2003)
Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients -: art. no. e82
E Ars et al.
JOURNAL OF MEDICAL GENETICS (2003)
Immunohistochemical demonstration of EMA/Glut1-positive perineurial cells and CD34-positive fibroblastic cells in peripheral nerve sheath tumors
T Hirose et al.
MODERN PATHOLOGY (2003)
Dynamic regulation of the Ras pathway via proteolysis of the NF1 tumor suppressor
K Cichowski et al.
GENES & DEVELOPMENT (2003)
Targeting ras signalling pathways in cancer therapy
J Downward
NATURE REVIEWS CANCER (2003)
Malignant peripheral nerve sheath tumours in neurofibromatosis 1
DGR Evans et al.
JOURNAL OF MEDICAL GENETICS (2002)
Neurofibromatosis: clinical presentations and anaesthetic implications
NP Hirsch et al.
BRITISH JOURNAL OF ANAESTHESIA (2001)
Single cell Ras-GTP analysis reveals altered Ras activity in a subpopulation of neurofibroma Schwann cells but not fibroblasts
LS Sherman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Growth hormone deficiency in children with neurofibromatosis type 1 without suprasellar lesions
R Vassilopoulou-Sellin et al.
PEDIATRIC NEUROLOGY (2000)
分享论文
